ArticleScientific reports2021

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.

Hany M Dabbous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.